EUA
Helix SARS-CoV-2 Test
FDA Emergency Use Authorization · Helix OpCo LLC (dba Helix) · Jul 14, 2022
Key facts
| Product | Helix SARS-CoV-2 Test |
|---|---|
| Company | Helix OpCo LLC (dba Helix) |
| Product type | Real-time RT-PCR, Home Collection, Multiple Targets, Screening |
| Date | Jul 14, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: